Over The Counter

The stoppage of over-the-counter exchange of scrapped currency notes had a mixed effect in Tamil Nadu today with more people queueing up in front of ATMs amid continuing cash crunch, while the rush eased out at banks much to the relief of their employees.

Dr Reddy's launches pain relief spray in Indian market

The spray will be available across the country in two sizes - pocket pack at Rs 99 and home pack for Rs 130 -- Dr Reddy's Laboratories said in a statement.

ADRs of over 50 Indian cos to trade over-the-counter in US

This is consequent to the government's new Depository Receipts Scheme, 2015, which permits for unsponsored ADRs for the first time. An unsponsored ADR is created by a foreign depository bank without the participation or consent of the issuer/company.

Pharma OTC: A step beyond generic drugs

As patents expire and generic drugs becoming available, pharma companies are looking forward to penetrate in the Over the Counter (OTC) market.

Sun Pharma to enter lucrative oral contraceptive mkt in US

Sun Pharma is all set to enter the lucrative oral contraceptive market in the US, but the going won’t be easy with the entrenched players like Teva and Watson dominating the market. CNBC-TV18’s Archana Shukla reports Sun will even have to take on its Indian peers like Glenmark and Lupin, who have an early mover advantage.

Espirito Santo Sec's health forecast for 3 pharma stocks

While the market has been weak, the pharma sector has remained steadfastly resilient. Chirag Talati, Pharma Analyst, Espirito Santo Securities talks about what is making news in the pharma space.

Dr Reddy's launches OTC drug in the US market

Dr Reddy's Laboratories today said it has launched two over-the-counter (OTC) drugs used to treat seasonal allergies such as itchy nose and sneezing, in the US market.

Mahindra Satyam back into black; to wind down ADS next year

Buoyed by improved business, IT company Mahindra Satyam today said it swung into the black in the April-June quarter, logging a Rs 225.2 crore profit, and unveiled plans to exit US stock market by 2012.

Mahindra Satyam to stop ADS programme in 2012

Software exporter Mahindra Satyam today said it plans to wind down its American Depository Share programme in 2012 due to regulatory issues with the US market regulator SEC.

Piramal sees revival in CRAMs, growth in OTC biz

Ajay Piramal, chairman of the company talks to CNBC-TV18's Ekta Batra about the outlook for the company.

Will close deal with J&J in next 2 weeks: JB Chemicals

Pranabh Mody, President, JB Chemicals in an interview with CNBC-TV18 said that the company is now focusing on selling the Russian over-the-counter (OTC) business and this deal with Johnson & Johnson (J&J) is likely to close in the next two weeks.

Piramal Healthcare to foray into financial services

Pharma major Piramal Healthcare is expanding into the financial services sector and plans to set up two NBFCs which will lend to infrastructure and other sectors.

Why are cos slowly switching to exchange traded options?

Arun Sax Sekhsaria, MD of DD Cotton, Maulik Shah, CFO of Rosy Blue India and Satyajit Kanjilal, CEO of Forexserve, gave their views on why exchange-traded options have not yet met with the same amount of success as exchange-traded futures.